+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

From
From
Active Pharmaceutical Ingredient (API) Market in the US 2025-2029 - Product Thumbnail Image

Active Pharmaceutical Ingredient (API) Market in the US 2025-2029

  • Report
  • May 2025
  • 177 Pages
  • United States
From
Antibody Drug Conjugates Market Report 2025-2035 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2025-2035

  • Report
  • December 2024
  • 342 Pages
  • Global
From
Pediatric Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Pediatric Clinical Trials - Global Strategic Business Report

  • Report
  • October 2026
  • 389 Pages
  • Global
From
Omics-based Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Omics-based Clinical Trials - Global Strategic Business Report

  • Report
  • October 2026
  • 176 Pages
  • Global
From
Translational Regenerative Medicine Market Report 2024-2034 - Product Thumbnail Image

Translational Regenerative Medicine Market Report 2024-2034

  • Report
  • February 2024
  • 270 Pages
  • Global
From
From
Cardiomyopathy Therapies - Global Strategic Business Report - Product Thumbnail Image

Cardiomyopathy Therapies - Global Strategic Business Report

  • Report
  • October 2026
  • 227 Pages
  • Global
From
From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 308 Pages
  • Global
From
From
Atherosclerosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 181 Pages
  • Global
From
Pericarditis Drugs - Global Strategic Business Report - Product Thumbnail Image

Pericarditis Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 289 Pages
  • Global
From
From
Fondaparinux - Global Strategic Business Report - Product Thumbnail Image

Fondaparinux - Global Strategic Business Report

  • Report
  • October 2026
  • 180 Pages
  • Global
From
Heart Failure Drugs - Global Strategic Business Report - Product Thumbnail Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 155 Pages
  • Global
From
Hemorrhagic Stroke Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemorrhagic Stroke Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 287 Pages
  • Global
From
Loading Indicator